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448 • 1996 Annual Meeting Abstracts MEDICAL DECISION MAKING
PROFESSIONALS' OPINIONS ABOUT QUESTIONS TO ADDRESS WITH CURABLE PROSTATE 
CANCER PATIENTS. D Feldman-Stewart, MD Brundane. C Havter. P Grootne. J Davidson. C Nickel. 
Radiation Oncology Research Unit, Queen's University, Kingston, Ontario, Canada.
The study was designed to determine what questions health-care professionals think should, and 
should not, be addressed with their patients who have curable prostate cancer before treatment decisions 
are made, A survey was distributed to all radiation therapists (RTs), nurses and doctors (radiation and 
medical oncologists) involved in treating prostate cancer patients in Ontario cancer centres and to all 
urologists practicing in Ontario. Participants were given a scenario describing a ease o f curable 
prostate cancer and asked to judge the importance, using one o f four categories (essential I  important I 
no opinion ! avoid), of addressing cach o f 78 questions.
O f 538 surveys sent out (250 to RTs, 50 to nurses, and 238 to doctors), 244 surveys (45%) have 
been returned to date.
AU 78 questions were judged ’’essential" by someone in each group; the most frequently assigned 
"essential" question by RTs related to patient autonomy and to treatment toxicity by both nurses and 
doctors. Most respondents thought most o f the questions were at least "important"': 74, 73 and 70 
questions were "essentia!" or ‘’important"' to at least 50% o f RTs, nurses and doctors, respectively.
Many of those questions, however, were also identified by co-professionals as questions to be avoided.
The number o f questions assigned to each category varied considerably across respondents. The 
number of questions considered "essential" ranged from (median in brackets) 1-77 (41), 18-71(39), 
0-71(24) for RTs, nurses, and doctors, respectively. "Avoid" questions ranged (median) from 0-41(1), 
0-33(1), 0-41(1), by RTs, nurses, and doctors, respectively.
At least some professionals consider a wide variety of questions as "essential" to address with 
patients before treatment decisions are made but the scope varies greatly across individuals in cach 
profession. In addition, every question that someone thinks should be avoided is thought by others 
within the same profession as at least "important” to address. The resuUs bode poorly for attempts to 
standardize information provision and for adherence to the etliical principles underpinning informed 
consent.
THE ALLOCATION OF PALLIATIVE TREATMENT IN END-STAGE DISEASE 
AMONG AN AIDS POPULATION.
DA C he r in JJ  Dc Jong. SJ Dodd. School of Social Work. University of Southern California. 
Los Anaeles. CA.
Offering a mix of palliative and curative services to terminal H1V-AIDS home bound 
patients which focus on the biopsychosoci al domains of the terminal disease trajectory, 
versus a singular focus on acute medical care, facilitates decision making.
One hundred and sixty-eight (n-l(j8) HI V-AIDS home cate patients were randomly 
assigned to a conventional model of home care stressing acute services only (n=s81) and an 
experimental model of care, a blended treatment model (n=78). The conventional mode! was 
staffed by nurse case-managcrs, while the blended model was ease-managed by a multi” 
disciplinary team of a nurse and a social worker. Care in the two models was evaluated over 
eight months. Seventy percent of the study sample were admitted to home carc services 
diagnosed with either CM V retinitus or wasting.
Results demonstrated that costs of care inclusive of labor costs and medication costs were 
$2,600 lower (p = .01) in the experimental model of care versus the conventional model; this 
was for a mean length of stay of 120 days (on home care services). The experimental model 
produced greater numbers of acknowledgments of the patients terminal prognosis and a 
greater number of hospice admissions over conventional care. The experimental group 
decided for admission for hospice earlier than the conventional group and had twice as many 
days in hospice service compared to the conventional care model.
Ovcral I the experimental model facilitated decision making in the patient system versus 
the conventional model with regard to key end-slage decision points.
CHOLESTEROL-LOWERING MEDICATION IN PRIMARY PREVENTION: PHYSICIANS' 
OPINIONS ABOUT PATIENTS' DECISION AIDS
HA Llewellvn-Thomas. PG Norton. M_Mc|adv. M Paterson. Clinical Epidemiology Unit, Sunnybrook 
Health Science Centre, Toronto, Ontario, Canada.
Earlier studies highlighted the need to develop, test, and disseminate decision aids for patients 
considering a cholesterol-lowering agent for primary prevention. However, failure to take into account 
the physician's perspective when developing and evaluating such aids may undermine iheir introduction 
Into family practice settings.
Using the College of Physicians and Surgeons of Ontario registrant data base and a formal survey 
strategy (Dillman 1978), a questionnaire was mailed to a random sample o f family physicians and 
general practitioners, The questionnaire described the proposed decision aid, asked respondents to 
indicate its acceptability, then obtained Likcrt ratings (1 = "not at all important"; 5 - "extremely 
important") for including 16 informational items in the aid, as well as using different measures (7 
baseline, 16 outcome) to evaluate its clinical effectiveness.
13 8 physicians (response rate: 75%) provided useable data, 123 (89%) indicated that the proposed 
aid would have a placc in their practice. > 80% of respondents ascribed importance ratings of *4' or ’5' 
to: 8 Information Items (description of drug regimen, costs to patient, qualitative description o f side 
effects, qualitative and quantitative descriptions of CHD risk without and with medication, and an 
illustration of the effects of modifying other risk factors); 1 Baseline Measure (patient's age); and 6 
Outcome Measures (level of understanding of alternatives' risks/benefits, clarity about factors involved 
in decision, confidence in ability to make informed choice, confidence in physician-patient relationship, 
lime with physician attributable to use of aid, and 'compliance' with decision).
These results imply that there is physician consensus about the elements to include in the design and 
evaluation o f an aid for this clinical situation; these consensual data wiEl be used to guide the 
development and assessment o f the aid itself. Furthermore, this survey strategy serves as a model for 
obtaining physician opinions about the design and testing of aids for other clinical applications.
ASSESSMENT OF THE UT ILITY OF PRO PH YLA CT IC  M ASTECTOMY IN W O M E N  W ITH  
A GENETIC  PRED ISPO SIT IO N  TO BREAST CANCER
I Ilnic. LCG Verhoef. PFM Stalmeier, W AJ van Daal and the Nijmegen Breast C ancer Working 
Party. Nijmegen University Hospital, Nijmegen, The Netherlands.
Background. Female carriers o f the breast/ovarian cancer susceptibility genes BRCA1 and BRCA2 
are at a high breast cancer risk (85%). They face the choice between prophylactic mastectomy (PM) or 
breast cancer screening. For this treatment choice, a decision support procedure was developed.
Purpose', The assessment of the feasibility, constant proportional tradeoff and reliability of utility 
assessment by the time tradeoff test (TTO) in this high-risk group.
Methods. 24 women with a (suspected) BRCA1/BRCA2 mutation were provided with comprehen­
sive oral, written and audiovisual information. The utility o f PM was assessed on two occasions. 
Utilities assessed on the last occasion were used for individual decision analyses If  there was a 
discrepancy between the two test replications leading to different decision analysis results, the woman 
was tested a third time. In order to test proportionality, the TTO consisted of four items, each with a 
different longevity. Proportionality was tested by MANOVA with factors 'longevity' and 'icplicalion'
Results. 20 of 24 women underwent DN/Vtesting; in four women this was impossible for technical 
reasons. Seven women were tested positive, two were negative and for 11 women DNA-test results arc 
not yet available. Two women (8%) did not complete the decision support procedure. Five women 
performed the TTO a third time. The mean utility of PM in the last session was 0.67 (SD=0.32). 
Proportionality was not violated [F(3, 63)=0.29, p=0.83]. Furthermore, the ’replication' effect was not 
significant [F(l, 21)=0.93, p=0.345], For each individual and for each replication, an average utility 
value was computed over the four TTO-items. The Pearson correlation coefficient between these 
average utilities of the two last sessions was 0.96. The outcome of the individual decision analyses 
(assuming that the mutation was present, except for two women who were BRCA-negative) was 12 
times PM and 10 times breast cancer screening.
Conclusions. TTO utilities o f PM cover a wide range, which results in different treatment choices 
Therefore, it is necessary to obtain individual utilities. According to our preliminary results, individual 
utility assessment by the TTO in this patient group is feasible, valid and reliable.
THE RESULTS OF DIRECT AND INDIRECT TREATMENT COMPARISONS IN 
META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS 
HC Bucher, GH QuvatL L Griffith. S Walter Department of Clinical Epidemiology & 
Biostatistics, McMaster University, Hamilton, Canada
When little or no data directly comparing two treatments are available, 
investigators often rely on indirect comparisons from studies testing the treatments 
against standard treatment or placebo. One approach to indirect comparison is to pool 
findings from the active treatment arms of the original controlled trials. This approach 
offers no advantage over a comparison of observational study data and is prone to 
bias.
We present an alternative model that evaluates ihe differences between treatment 
and placebo in two sets of clinical trials, and preserves the experimental study design. 
We apply the method to data of randomized controlled trials comparing directly 
trimethoprim-sulphamethoxazole and dapsone/pyrimethamine or both prophylactic 
regimen indirectly with aerosolized pentamidine as prophylaxis against Pneumocystis 
carinii pneumonia in HIV infected patients. The indirect comparison showed 
substantial increased benefit from the former (odds ratio 0.36,95% Cl 0.21 to 0.65), 
while direct comparison from randomized trials suggests a much smaller difference 
(risk ratio 0.64, 95% Cl 0.45 to 0.90, p-value for difference of effect - Q. 10).
Direct comparisons of treatment should be sought. When direct comparisons are 
unavailable, indirect comparison meta-analysis should evaluate the magnitude of 
treatment effects across studies, recognizing the limited strength of inference.
STRESS ECHOCARDIOGRAPHY, POSITRON EMISSION TOMOGRAPHY, AND 
MAGNETIC RESONANCE IMAGING FOR THE DIAGNOSIS OF 
CORONARY ARTERY DISEASE: ARE THEY UP TO THE CHALLENGE?
Maria GM Hunlnk. University of Groningen, The Netherlands, and 
Harvard School oí Public Health, Boston, Massachusetts,
Purpose: To evaluate whether stress echocardiography, exercise positron emission 
tomography (PET), and magnetic resonance imaging (MRI) could become cost-effective 
alternatives compared to exercise thallium scintigraphy for the diagnosis of coronary artery 
disease.
Methods; Based on published data, we constructed a summary receiver operating 
characteristic (ROC) curve for exercise thallium scintigraphy. Subsequently, we constructed 
challenge ROC curves for stress echocardiography, PET, and MRI. Challenge ROC curves 
represent the threshold pairs of true and false positive rates that the new tests would have 
to attain to be cost-effective compared to exercise thallium scintigraphy. We assumed a 
threshold wllltngness-to-pay of $50,000/QALY gained. In sensitivity analysis a range of 
values for the probability of disease, proportion of unlnterpretable test results, costs of the 
tests, QALY’s gained with revascularization, and incremental costs with revascularization 
were explored. Published results of the diagnostic performance of the new tests were 
compared to the derived challenge ROC curves.
ResuUs; The challenge ROC curves
and corresponding published results 
are presented. For all three tests 
published results of the diagnostic 
parameters were above the challenge 
ROC curves. These results were lairly 
robust in a sensitivity analysis.
Conclusions: This analysis suggests that stress echocardiography, PET, and MRI meet 
the challenge and all three tests show promise in providing cost-effective alternatives to 
exerejse thallium scintigraphy for the d agnosis of coronary artery disease.
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